Consolidated Balance Sheets - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Current Assets
Cash and cash equivalents	$ 23,044,844	$ 7,076,651
Restricted cash	5,000,722	0
Marketable securities	36,324,936	0
Accounts receivable, net of allowances of $0 at June 30, 2017 and December 31, 2016, respectively	335,646	138,774
Prepaid and other current assets	5,706,396	1,900,493
Current assets related to discontinued operations	0	15,533,043
Total current assets	70,412,544	24,648,961
Property, plant and equipment, net	432,853	705,439
Other assets	1,402,463	1,582,209
Other assets related to discontinued operations	0	26,577,834
Total assets	72,247,860	53,514,442
Current Liabilities
Accounts payable	1,114,122	2,226,580
Accrued liabilities	12,408,604	2,659,433
Long-term debt, current	0	3,126,457
Notes payable, current	578,353	563,777
Due to PCT	450,315	1,681,594
Current liabilities related to discontinued operations	0	10,925,052
Total current liabilities	14,551,394	21,182,893
Notes payable	23,290	159,180
Long-term debt	0	2,524,897
Other long-term liabilities	3,636,538	389,858
Liabilities related to discontinued operations	0	5,791,134
Total liabilities	18,211,222	30,047,962
Commitments and Contingencies
Redeemable Securities - Non-Controlling Interests	0	19,400,000
Stockholders' Equity
Preferred stock, authorized, 20,000,000 shares Series B convertible redeemable preferred stock liquidation value, 1 share of common stock, $.01 par value; 825,000 shares designated; issued and outstanding, 10,000 shares at June 30, 2017 and December 31, 2016	100	100
Common stock, $.001 par value, authorized 500,000,000 shares; issued and outstanding, 8,912,602 and 8,205,791 shares, at June 30, 2017 and December 31, 2016, respectively	8,913	8,206
Additional paid-in capital	430,606,930	410,372,049
Treasury stock, at cost; 11,080 shares at June 30, 2017 and December 31, 2016, respectively	(707,637)	(707,637)
Accumulated deficit	(375,429,627)	(404,788,809)
Accumulated other comprehensive income	(57,860)	0
Total Caladrius Biosciences, Inc. stockholders' equity	54,420,819	4,883,909
Noncontrolling interests	(384,181)	(817,429)
Total equity	54,036,638	4,066,480
Liabilities and Equity, Total	$ 72,247,860	$ 53,514,442

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Name:	us-gaap_AccountsPayableCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.